LINC00052 and breast carcinoma: In this regard, LINC00052 acts as a suppressor gene, at least in hepatocarcinoma [10,11], pancreatic cancer [12], gliomas [13,14], and possibly breast cancer [15–18], while remarkably, it appears to function as an oncogene in gastric cancer [19].